Patents by Inventor Eilezer Gileadi

Eilezer Gileadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8303643
    Abstract: A device and method are provided for spontaneous electrochemical production of therapeutic species, in vivo. An active metal is implanted in the tissue. The metal undergoes corrosion, thus acting as a reducing agent to constituents in the tissue, so as to cause these constituents to form the therapeutic agents.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: November 6, 2012
    Assignee: Remon Medical Technologies Ltd.
    Inventors: Avi Penner, Eilezer Gileadi
  • Publication number: 20100233237
    Abstract: A device and method are provided for spontaneous electrochemical production of therapeutic species, in vivo. An active metal is implanted in the tissue. The metal undergoes corrosion, thus acting as a reducing agent to constituents in the tissue, so as to cause these constituents to form the therapeutic agents.
    Type: Application
    Filed: May 21, 2010
    Publication date: September 16, 2010
    Inventors: Avi Penner, Eilezer Gileadi
  • Patent number: 7727221
    Abstract: A device and method are provided for spontaneous electrochemical production of therapeutic species, in vivo. An active metal is implanted in the tissue. The metal undergoes corrosion, thus acting as a reducing agent to constituents in the tissue, so as to cause these constituents to form the therapeutic agents.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: June 1, 2010
    Assignee: Cardiac Pacemakers Inc.
    Inventors: Avi Penner, Eilezer Gileadi
  • Publication number: 20040230225
    Abstract: A device and method are provided for spontaneous electrochemical production of therapeutic species, in vivo. An active metal is implanted in the tissue. The metal undergoes corrosion, thus acting as a reducing agent to constituents in the tissue, so as to cause these constituents to form the therapeutic agents.
    Type: Application
    Filed: November 19, 2003
    Publication date: November 18, 2004
    Inventors: Avi Penner, Eilezer Gileadi